Transgenic Expression of Vitamin D Receptor in Gut Epithelial Cells Ameliorates Spontaneous Colitis Caused by Interleukin-10 Deficiency

Digestive Diseases and Sciences

Volumn 60, Issue 7, 2015, Pages 1941-1947

  Golan, Maya Aharoni ^a   Liu, Weicheng ^a   Shi, Yongyan ^a,b   Chen, Li ^a,b   Wang, Jiaolong ^a,b   Liu, Tianjing ^a,b   Li, Yan Chun ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Colitis; Inflammatory bowel diseases; Interleukin 10; Mucosal epithelial barrier; Vitamin D receptor

Indexed keywords

CASPASE 3; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MYELOPEROXIDASE; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; VILLIN; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASCENDING COLON; CD4+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DESCENDING COLON; GENE INACTIVATION; IMMUNOCOMPETENT CELL; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; LAMINA PROPRIA; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-10; INTESTINAL MUCOSA; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, CALCITRIOL;

EID: 84930822733     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-015-3634-8     Document Type: Article

References (38)

1. Salim SY, Soderholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:362–381.
2. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol. 2005;2:416–422.
3. Gibson PR. Increased gut permeability in Crohn’s disease: is TNF the link? Gut. 2004;53:1724–1725.
4. Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, et al. Molecular mechanisms of vitamin D action. Calcif Tissue Int. 2013;92:77–98.
5. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517.
6. Lim WC, Hanauer SB, Li YC. Mechanisms of Disease: vitamin D and inflammatory bowel disease. Nat Clin Practice Gastroenterol Hepatol. 2005;2:308–315.
7. Bischoff SC, Herrmann A, Goke M, Manns MP, von zur Muhlen A, et al. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol. 1997;92:1157–1163.
8. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:192–199.
9. Marx G, Seidman EG. Inflammatory bowel disease in pediatric patients. Curr Opin Gastroenterol. 1999;15:322–325.
10. Pappa HM, Gordon CM, Saslowsky TM, Zholudev A, Horr B, et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics. 2006;118:1950–1961.
11. Scharla SH, Minne HW, Lempert UG, Leidig G, Hauber M, et al. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn’s disease and ulcerative colitis). Exp Clin Endocrinol. 1994;102:44–49.
12. Schulte CM. Review article: bone disease in inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(Suppl 4):43–49.
13. Sinnott BP, Licata AA. Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review. Endocr Pract. 2006;12:622–629.
14. Souza HN, Lora FL, Kulak CA, Manas NC, Amarante HM, et al. Low levels of 25-hydroxyvitamin D (25OHD) in patients with inflammatory bowel disease and its correlation with bone mineral density. Arq Bras Endocrinol Metabol. 2008;52:684–691.
15. Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology. 2012;142:482–489.
16. Liu W, Chen Y, Golan MA, Annunziata ML, Du J, et al. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest. 2013;123:3983–3996.
17. Chen Y, Du J, Zhang Z, et al. MicroRNA-346 mediates tumor necrosis factor-α-induced down-regulation of gut epithelial vitamin D receptor in inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20:1910–1918.
18. Kong J, Zhang Z, Musch MW, Ning G, Sun J, et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008;294:G208–G216.
19. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263–274.
20. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest. 1996;98:1010–1020.
21. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr. 2000;130:2648–2652.
22. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol. 2003;17:2386–2392.
23. Kong J, Zhu X, Shi Y, Liu T, Chen Y, et al. VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system. Mol Endocrinol. 2013;27:2116–2125.
24. Qiu W, Wu B, Wang X, Buchanan ME, Regueiro MD, et al. PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. J Clin Invest. 2011;121:1722–1732.
25. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 1999;10:39–49.
26. Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity. 2011;34:566–578.
27. Huber S, Gagliani N, Esplugues E, O’Connor W Jr, Huber FJ, et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3(−) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity. 2011;34:554–565.
28. Glocker EO, Frede N, Perro M, Sebire N, Elawad M, et al. Infant colitis—it’s in the genes. Lancet. 2010;376:1272.
29. Kotlarz D, Beier R, Murugan D, Diestelhorst J, Jensen O, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012;143:347–355.
30. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998;66:5224–5231.
31. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694–702.
32. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med. 1995;182:1281–1290.
33. Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, et al. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol. 2009;296:G135–G146.
34. Madsen KL, Malfair D, Gray D, Doyle JS, Jewell LD, et al. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis. 1999;5:262–270.
35. Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, et al. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology. 2010;151:2423–2432.
36. Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol. 2011;7:337–345.
37. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2008;8:685–698.
38. Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol. 2011;11:584–596.